Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Biotech Companies to Discover Ebola, Zika Vaccines

Two biotechnology companies are collaborating to discover new vaccines protecting against Ebola and Zika viruses that present global threats to public health. . . . → Read More: Biotech Companies to Discover Ebola, Zika Vaccines

Pharma Firms Start Non-Communicable Disease Initiative

A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions. . . . → Read More: Pharma Firms Start Non-Communicable Disease Initiative

Sleeping Sickness Treatment Found in Cancer Drug

An experimental drug designed to treat solid tumor cancers was shown in lab tests to rid mice of human African trypanosomiasis, also known as sleeping sickness. . . . → Read More: Sleeping Sickness Treatment Found in Cancer Drug

$1 Million Challenge Seeks Child Health Solutions

A new challenge seeks technologies and solutions to reduce child mortality and improve the health of children in low-resource regions of the world. . . . → Read More: $1 Million Challenge Seeks Child Health Solutions

Start-Up Licenses Genetics Technology for HIV Diagnostics

David Raiser, left, and Iain MacLeod, founders of Aldatu Biosciences (Aldatu Biosciences)

19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed.

Aldatu . . . → Read More: Start-Up Licenses Genetics Technology for HIV Diagnostics

Tropical Disease Diagnostics Now on Market

The Carter Center, founded by former U.S. president Jimmy Carter, has been instrumental in eradicating river blindness in Africa. (share.america.gov)

12 April 2016. PATH research institute and medical test developer Standard Diagnostics are making available tests for the tropical diseases onchocerciasis and lymphatic filariasis. The rapid, point-of-care tests are designed to help health authorities . . . → Read More: Tropical Disease Diagnostics Now on Market

Ebola Monitoring System Devised with Genome Sequencing

Ebola genome sequencing lab in Guinea (European Mobile Lab)

3 February 2016. An international team of scientists and engineers designed a mobile system using a hand-held genome sequencing device that provided real-time monitoring of the Ebola outbreak in West Africa in 2015. Researchers led by microbiologists Nicholas Loman and Joshua Quick at University of . . . → Read More: Ebola Monitoring System Devised with Genome Sequencing

Regeneron to Develop Antibody Therapy for Ebola

Scanning electron micrograph shows Ebola virus budding on monkey kidney cells (Defense.gov)

21 September 2015. Regeneron Pharmaceuticals Inc. received a contract from the U.S. Department of Health and Human Services to develop an engineered antibody designed to treat Ebola infections. The initial $17 million contract from HHS’s Biomedical Advanced Research and Development Authority or . . . → Read More: Regeneron to Develop Antibody Therapy for Ebola

Point-of-Care Ebola Test Found Accurate in Field Test

Woman being evaluated at an Ebola clinic in Sierra Leone (Rebecca Rollins, Partners In Health)

26 June 2015. A commercial point-of-care test detecting Ebola virus in the blood of a patient was shown in a field test in Sierra Leone to be as accurate as tests sent to remote labs for analysis. Results of . . . → Read More: Point-of-Care Ebola Test Found Accurate in Field Test

FDA Approves Pediatric HIV Drug Formulation

Scanning electron micrograph of HIV particles infecting a human T cell (NIH.gov)

5 June 2015. The U.S. Food and Drug Administration approved an application for a current HIV drug formulated to better treat infections in infants and young children, especially in limited resource regions. The formulation is a combination of lopinavir and ritonavir in . . . → Read More: FDA Approves Pediatric HIV Drug Formulation